Between the second and third quarters of 2025, around 17 percent of U.S. adults aged 40 to 49 and 50 to 64 years reported using GLP-1 injectables for weight loss. The obesity rate has declined by five percent in the 50 to 64 age group since 2022.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Gallup. (October 28, 2025). Share of GLP-1 injectables users in the United States for the second and third quarters of 2025, by age [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 22, 2026, from /statistics/1661141/glp-1-injectables-users-in-the-us/
Gallup. "Share of GLP-1 injectables users in the United States for the second and third quarters of 2025, by age ." Chart. October 28, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 22, 2026. /statistics/1661141/glp-1-injectables-users-in-the-us/
Gallup. (2025). Share of GLP-1 injectables users in the United States for the second and third quarters of 2025, by age . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 22, 2026. /statistics/1661141/glp-1-injectables-users-in-the-us/
Gallup. "Share of Glp-1 Injectables Users in The United States for The Second and Third Quarters of 2025, by Age ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 28 Oct 2025, /statistics/1661141/glp-1-injectables-users-in-the-us/
Gallup, Share of GLP-1 injectables users in the United States for the second and third quarters of 2025, by age ÌÇÐÄÆƽâ°æ, /statistics/1661141/glp-1-injectables-users-in-the-us/ (last visited July 22, 2026)
Share of GLP-1 injectables users in the United States for the second and third quarters of 2025, by age [Graph], Gallup, October 28, 2025. [Online]. Available: /statistics/1661141/glp-1-injectables-users-in-the-us/
